The gp130F/F mutation impairs SOCS3-mediated negative feedback of STAT3 signaling, leading to hyperactivation of the IL-6/STAT3 pathway that is frequently dysregulated in human gastric cancer (Ouyang et al., 2017; Kim et al., 2017; Ernst et al., 2008). Here, IL6 is linked to gastric cancer.